Recent studies have the promise of RMP1-14, a specifically engineered anti-mouse PD-1 antibody , for enhancing cancer immunotherapy . Unlike conventional approaches, RMP1-14 exhibits enhanced binding to https://heathyqiu094955.wikicorrespondence.com/6624207/employing_this_a_new_murine_programmed_death_1_agent_in_immune_therapy